evolcSign inStart free
Menu

Oncosyne

Tumoroid-based drug screening and predictive diagnostics for pharmaceutical companies and cancer care providers

Oslo, NorwayFounded 2020oncosyne.noWebsite technologies

+ Add to sales board

Highlights

  • Hiring1 open role
  • New on EvolcAdded 2026-10-30

About Oncosyne

Oncosyne develops the iCAN platform, which uses patient-derived tumoroids for drug screening and analysis in colorectal and pancreatic cancer. It offers the platform for pharmaceutical drug discovery and development and is developing it for predictive cancer diagnostics.

Pharmaceutical companies use its tools to support drug discovery and development; oncologists may use predictive tests to select treatments. Its first colorectal cancer test is being validated in a clinical performance study, and a pancreatic cancer test is under development.

Oncosyne AS was founded in 2020 and is headquartered in Oslo, Norway. The company has a team spanning cancer research, product development, laboratory science and strategic partnerships.

Product: iCAN tumoroid platform and drug-screening services for pharmaceutical development, with predictive cancer diagnostics under development.

Jobs at Oncosyne (1)

Oncosyne is hiring for one role.

Leadership

More biotech & pharma companies

  • Pharma Holdings

    Develops intranasal antimicrobial drugs for patients with respiratory viral infections
    Tromsø, NorwayBiotech & pharmaFounded 2016
    New on Evolc

  • Pluvia

    Develops small-molecule drugs for patients with rare protein-misfolding disorders, starting with phenylketonuria (PKU)
    Bergen, NorwayBiotech & pharmaFounded 2015
    New on Evolc

  • Previwo

    Probiotic products for farmed salmon and trout that strengthen fish health in aquaculture
    Oslo, NorwayBiotech & pharmaFounded 2013
    New on Evolc

  • Prophylaxia

    Researches salmon signalling substances such as SNAP as a sea lice alternative for salmon farming
    Vikebukt, NorwayBiotech & pharmaFounded 2009
    New on Evolc

  • Quantidoc

    Immune barrier health monitoring for fish farms and hatcheries using its VERIBARR™ analyses of gills, skin and gut
    Bergen, NorwayBiotech & pharmaFounded 2013
    New on Evolc

  • Regenics

    Develops marine-derived wound care products for treating burns and chronic wounds
    Oslo, NorwayBiotech & pharmaFounded 2000
    New on Evolc

All biotech & pharma companies →

Website technologies

Older, unverified list. Detection dates and supporting evidence are not yet available.

  • Apache
  • Cookiebot
  • Google Tag Manager
  • WordPress